A case series and literature review of immune checkpoint inhibitors-associated myocarditis (ICIM) in non-small cell lung cancer
Early identification and intervention are critical for ICIM. The core treatment is ICI discontinuation plus glucocorticoid administration, but the optimal second-line regimen for glucocorticoid-resistant patients requires further investigation.
Authors
- Yue Sun (ORCID: https://orcid.org/0000-0002-3789-4453)
- Shi Lin (ORCID: https://orcid.org/0000-0003-2698-301X)
- Jinjun Jiang
- S Chen (ORCID: https://orcid.org/0000-0002-0855-9218)
- Yuan Liu
- Yuanlin Song
- Xiaomin Dai
- Yan Wang
- Jing Bi
- Jing Zhang
Institutions
- Sun Yat-sen University (CN)
- Shaoxing University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3389/fcvm.2025.1615085
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00